Back to Trades
Grant4
AMGEN INC
AMGN
Total Value
$6.4M
Company Information
- Company Name
- AMGEN INC
- Ticker Symbol
- AMGN
- CIK
- 0000318154
Insider Information
- Name
- REESE DAVID M
- Role
- EVP & Chief Technology Officer
- Location
- THOUSAND OAKS, CA
Officer
Filing Details
- Filing Date
- May 7, 2026
- Transaction Date
- May 5, 2026
- Accession Number
- 0000318154-26-000073
- Form Type
- 4
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| May 5, 2026 | Common Stock | 2,912 | — | Grant/Award | — |
| May 6, 2026 | Common Stock | 454 | $329.59 | Tax Withholding | $149.6K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| May 5, 2026 | Derivative | 19,002 | $329.59 | Grant/Award | $6.3M |
Footnotes
- (F1)The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan (the Equity Incentive Plan) and vest in four equal annual installments of 25% each, commencing on 5/5/2027, subject to proration based on the number of completed months of active employment in 2026. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
- (F2)These shares include 415 Dividend Equivalents (DEs) granted pursuant to the Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested Restricted Stock Units and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.
- (F3)These non-qualified stock options were granted pursuant to the Equity Incentive Plan and vest and are exercisable in four equal annual installments of 25% each, commencing on 5/5/2027, subject to proration based on the number of completed months of active employment in 2026.